PT  - JOURNAL ARTICLE
AU  - Liu, Jieqiong
AU  - Liu, Qiang
AU  - Li, Ying
AU  - Li, Qian
AU  - Su, Fengxi
AU  - Yao, Herui
AU  - Su, Shicheng
AU  - Wang, Quanren
AU  - Jin, Liang
AU  - Wang, Ying
AU  - Lau, Wan Yee
AU  - Jiang, Zefei
AU  - Song, Erwei
TI  - Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
AID  - 10.1136/jitc-2020-000696
DP  - 2020 May 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e000696
VI  - 8
IP  - 1
4099  - http://jitc.bmj.com/content/8/1/e000696.short
4100  - http://jitc.bmj.com/content/8/1/e000696.full
SO  - J Immunother Cancer2020 May 01; 8
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.